Return to work after allogeneic stem cell transplantation (SOPRALLO project)
Presented by Dr Yana Stepanishyna (Institut Jules Bordet, Brussels, Belgium)
Dr Yana Stepanishyna, a haematologist at the Institut Jules Bordet in Brussels, presents a preliminary analysis from the SOPRALLO project.
Allogeneic hematopoietic stem cell transplantation (HSCT) has significantly extended the survival of recipients. However, this progress is accompanied by the potential for long-term side effects, which can adversely impact the quality of life and reduce the capacity for return to work (RTW) among these patients. The current analysis focuses on socio-demographic predictive factors that may impact social maladjustment and RTW.
References:
Stepanishyna Y, EHA2024. #P1667
With the educational support of:
